Double Medical Technology Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Net Income	636.88	356.8	58.96	92.56	673.31
Depreciation & Amortization	136.64	122.8	111.9	95.51	70.85
Other Amortization	104.55	99.37	82.49	42	11.2
Loss (Gain) From Sale of Assets	-0.62	-0.27	-0.3	1.73	0
Asset Writedown & Restructuring Costs	15.79	0.93	0.88	1.91	0.94
Loss (Gain) From Sale of Investments	-4.72	-20.39	-15.35	-17.98	-21.41
Provision & Write-off of Bad Debts	-	6.02	-1.13	-2.07	16.24
Other Operating Activities	-23.65	64.83	57.46	4.52	18.43
Change in Accounts Receivable	-58.54	4.64	86.8	121.91	-179.38
Change in Inventory	-109.47	-220.53	-422.18	-418.26	-140.44
Change in Accounts Payable	88.78	26.68	118.18	103.13	189.28
Change in Other Net Operating Assets	43.66	7.87	-	105.55	38.08
Operating Cash Flow	831.34	442.3	73.89	128.44	673.26
Operating Cash Flow Growth	87.96%	498.58%	-42.47%	-80.92%	21.14%
Capital Expenditures	-133.51	-270.46	-305.72	-285.07	-235.11
Sale of Property, Plant & Equipment	1.3	1.37	1.59	0.44	0.01
Cash Acquisitions	-	-	-	1.66	-88.02
Investment in Securities	-305.34	406.86	-213.77	40.75	-96.03
Other Investing Activities	-242.11	13.75	9.89	16.74	22.59
Investing Cash Flow	-679.66	153.6	-508.01	-225.61	-396.76
Long-Term Debt Issued	94.87	159.05	532.61	50.77	1.11
Total Debt Issued	94.87	159.05	532.61	50.77	1.11
Long-Term Debt Repaid	-167.84	-377.83	-12.33	-11.36	-8.33
Total Debt Repaid	-167.84	-377.83	-12.33	-11.36	-8.33
Net Debt Issued (Repaid)	-72.96	-218.78	520.28	39.41	-7.22
Issuance of Common Stock	50.43	-	-	488.32	79.34
Repurchase of Common Stock	-	-234.98	-	-75.68	-2.92
Common Dividends Paid	-214.36	-118.07	-9.43	-209.38	-324.11
Other Financing Activities	-37.01	-45.37	-14.65	2.5	-4.42
Financing Cash Flow	-273.91	-617.2	496.2	245.16	-259.33
Foreign Exchange Rate Adjustments	5.71	-11.37	1.06	4.31	-3.55
Net Cash Flow	-116.52	-32.68	63.14	152.3	13.61
Free Cash Flow	697.83	171.84	-231.82	-156.63	438.15
Free Cash Flow Growth	306.09%	-	-	-	4.66%
Free Cash Flow Margin	26.83%	8.05%	-15.12%	-10.92%	21.97%
Free Cash Flow Per Share	1.71	0.41	-0.55	-0.37	1.09
Cash Income Tax Paid	329.28	175.28	106.5	210.18	310.97
Levered Free Cash Flow	561.8	73.43	-105.63	-240.44	303.33
Unlevered Free Cash Flow	561.8	77.48	-101.16	-238.5	303.68
Change in Working Capital	-33.52	-187.8	-221.01	-89.74	-96.3

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.